In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...

In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...

In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after prior treatment, experienced comparable outcomes whether they received ...

Members of Fulcrum management will be joined by Dr. Sheinei Alan, Director of the Inova Adult Sickle Cell Program and Assistant Professor at UVA School of Medicine, and Dr. Martin Steinberg, Professor ...

Emerging tests and treatment strategies guide more tailored approaches and ease the burden on patientsORLANDO, Fla., Dec. 6, ...

The New Jersey Office of the Secretary of Higher Education (OSHE), in partnership with ReUp Education, today released a new impact report on the State's groundbreaking Some College, No Degree (SCND) ...

‘Chief Medical Officer’s Annual Report 2025: Infections’ was published at 15:00 UK time on Thursday the 4th of December 2025. Prof Andrew Morris: Andrew is the President of the Academy of Medical ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...

Poster presentation highlights promising results from Phase 1b/2 TENACITY-01 study of CTD402 in T-Cell and myeloid leukemias Findings underscore potential to address unmet needs in multiple ...

ZKsync is retiring its original Lite network, formalizing a shift toward ZKsync Era and the ZK Stack as activity on the ...